Inventor · disambiguated record
Jean Xu
Also filed as: XU JEAN · XU JEAN J · XU JEAN JIDONG
53 granted patents·15 pending applications·421 citations·filing 1999–2025
98Inventor score
Top patents by PatentIndex Score
68 records- 0199US7893101B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2008·Granted Feb 22, 2011·44 cites·15 claims
- 0297US9365524B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2015·Granted Jun 14, 2016·22 cites·36 claims
- 0396US9814713B2Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their useSIGNAL PHARM LLC·Filed 2016·Granted Nov 14, 2017·14 cites·21 claims
- 0496US9096832B2Differentiation of human embryonic stem cellsXU JEAN·Filed 2008·Granted Aug 4, 2015·40 cites·38 claims
- 0596US9018243B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2013·Granted Apr 28, 2015·13 cites·21 claims
- 0696US8093283B2Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisinoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2010·Granted Jan 10, 2012·17 cites·42 claims
- 0795US9744195B2Differentiation of human embryonic stem cellsLIFESCAN INC·Filed 2015·Granted Aug 29, 2017·14 cites·16 claims
- 0895US9221788B2Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2013·Granted Dec 29, 2015·21 cites·77 claims
- 0995US8629173B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofMULLER GEORGE W·Filed 2011·Granted Jan 14, 2014·11 cites·39 claims
- 1094US8785184B2Differentiation of human embryonic stem cellsXU JEAN·Filed 2010·Granted Jul 22, 2014·31 cites·2 claims
- 1193US8802685B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesMULLER GEORGE·Filed 2012·Granted Aug 12, 2014·9 cites·61 claims
- 1293US8785185B2Differentiation of human embryonic stem cellsXU JEAN·Filed 2010·Granted Jul 22, 2014·32 cites·4 claims
- 1392US10882867B2Forms and compositions of a MK2 inhibitorCELGENE CAR LLC·Filed 2018·Granted Jan 5, 2021·8 cites·23 claims
- 1492US9359364B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2014·Granted Jun 7, 2016·10 cites·28 claims
- 1591US12343346B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2024·Granted Jul 1, 2025·0 cites·7 claims
- 1691US9629849B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2015·Granted Apr 25, 2017·7 cites·41 claims
- 1791US7843685B2Duct system for high power adapter cardsIBM·Filed 2008·Granted Nov 30, 2010·32 cites·10 claims
- 1890US9725699B2Differentiation of human embryonic stem cellsLIFESCAN INC·Filed 2014·Granted Aug 8, 2017·5 cites·8 claims
- 1990US9433606B2Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereofCELGENE CORP·Filed 2015·Granted Sep 6, 2016·3 cites·15 claims
- 2090US8158635B2Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewithBEAUCHAMPS MARIE G·Filed 2008·Granted Apr 17, 2012·26 cites·4 claims
- 2189US8741643B2Differentiation of pluripotent stem cells to definitive endoderm lineageREZANIA ALIREZA·Filed 2007·Granted Jun 3, 2014·7 cites·1 claims
- 2288US10704025B2Use of noggin, an ALK5 inhibitor and a protein kinase c activator to produce endocrine cellsJANSSEN BIOTECH INC·Filed 2017·Granted Jul 7, 2020·2 cites·19 claims
- 2388US9403829B2Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their useSIGNAL PHARM LLC·Filed 2012·Granted Aug 2, 2016·13 cites·29 claims
- 2487US9751853B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2015·Granted Sep 5, 2017·4 cites·10 claims
- 2587US9249121B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2014·Granted Feb 2, 2016·2 cites·53 claims
- 2687US2025281501A1Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2025·Application pending·0 cites
- 2786US9969713B2Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2017·Granted May 15, 2018·1 cites·15 claims
- 2886US2024002807A1Differentiation of human embryonic stem cellsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2985US10456424B2Pancreatic endocrine cells and methods thereofJANSSEN BIOTECH INC·Filed 2017·Granted Oct 29, 2019·3 cites·15 claims
- 3084US10463672B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2017·Granted Nov 5, 2019·2 cites·13 claims
- 3184US9150833B2Differentiation of human embryonic stem cellsXU JEAN·Filed 2010·Granted Oct 6, 2015·5 cites·14 claims
- 3283US11629153B2Forms and compositions of a MK2 inhibitorCELGENE CAR LLC·Filed 2020·Granted Apr 18, 2023·1 cites·33 claims
- 3383US9884062B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2017·Granted Feb 6, 2018·2 cites·34 claims
- 3480US10047090B2Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their useSIGNAL PHARM LLC·Filed 2017·Granted Aug 14, 2018·3 cites·4 claims
- 3580US2022125797A1Salts and solid forms of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2022·Application pending·0 cites
- 3679US10471104B2Lowering blood glucoseJANSSEN BIOTECH INC·Filed 2018·Granted Nov 12, 2019·1 cites·21 claims
- 3779US10076544B2Differentiation of human embryonic stem cellsXU JEAN·Filed 2010·Granted Sep 18, 2018·3 cites·39 claims
- 3877US11890304B2Pancreatic endocrine cells and methods thereofJANSSEN BIOTECH INC·Filed 2019·Granted Feb 6, 2024·0 cites·14 claims
- 3977US11708562B2Differentiation of human embryonic stem cellsJANSSEN BIOTECH INC·Filed 2019·Granted Jul 25, 2023·0 cites·18 claims
- 4076US9085551B2Solid forms of 3-(4-nitro-1-oxisoindolin-2-yl)piperidine-2,6-dioneCELGENE CORP·Filed 2013·Granted Jul 21, 2015·1 cites·5 claims
- 4175US12441985B2Methods for making insulin in vivoJANSSEN BIOTECH INC·Filed 2023·Granted Oct 14, 2025·0 cites·11 claims
- 4274US11241439B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2020·Granted Feb 8, 2022·0 cites·12 claims
- 4372US10596180B2Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the sameCELGENE CORP·Filed 2019·Granted Mar 24, 2020·0 cites·14 claims
- 4471US2020291360A1Use of noggin, an alk5 inhibitor and a protein kinase c activator, to produce endocrine cellsJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 4570US10005760B2Forms and compositions of an ERK inhibitorCELGENE CAR LLC·Filed 2015·Granted Jun 26, 2018·1 cites·21 claims
- 4669US11369642B2Methods for lowering blood glucoseJANSSEN BIOTECH INC·Filed 2019·Granted Jun 28, 2022·0 cites·4 claims
- 4769US7179890B2Vascular endothelial growth factor-xJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 20, 2007·1 cites·2 claims
- 4867US2017335289A1Differentiation of Human Embryonic Stem CellsLIFESCAN INC·Filed 2017·Application pending·0 cites
- 4966US2018305333A1Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and usesCELGENE CORP·Filed 2018·Application pending·0 cites
- 5064US9827243B2Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-oneSIGNAL PHARM LLC·Filed 2016·Granted Nov 28, 2017·0 cites·17 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jean Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →